Anti-wrinkle drugs to carry FDA's strongest warning

05/1/2009 | NYTimes.com

Botox, Dysport and other anti-wrinkle treatments must come with a black-box warning indicating that the drugs can spread from the injection site and trigger side effects such as difficulty swallowing and breathing, the FDA said. The agency added that adverse reactions were seen mainly in patients who were given excessive doses of the drugs for off-label use.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC